First Time Loading...

Treace Medical Concepts Inc
NASDAQ:TMCI

Watchlist Manager
Treace Medical Concepts Inc Logo
Treace Medical Concepts Inc
NASDAQ:TMCI
Watchlist
Price: 11 USD 2.71% Market Closed
Updated: May 4, 2024
Section:
 

Wall Street
Price Targets

TMCI Price Targets Summary
Treace Medical Concepts Inc

Wall Street analysts forecast TMCI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TMCI is 16.17 USD with a low forecast of 14.14 USD and a high forecast of 18.9 USD.

TMCI Lowest Forecast
Wall Street Target
14.14 USD
29% Upside
TMCI Average Forecast
Wall Street Target
16.17 USD
47% Upside
TMCI Highest Forecast
Wall Street Target
18.9 USD
72% Upside
Lowest
Price Target
14.14 USD
29% Upside
Average
Price Target
16.17 USD
47% Upside
Highest
Price Target
18.9 USD
72% Upside
Treace Medical Concepts Inc Competitors:
Price Targets
MASI
Masimo Corp
12% Upside
I
041830
InBody Co Ltd
33% Upside
6869
Sysmex Corp
21% Upside
IRTC
iRhythm Technologies Inc
38% Upside
MASI
Masimo Corp
12% Upside
I
041830
InBody Co Ltd
33% Upside
6869
Sysmex Corp
21% Upside
IRTC
iRhythm Technologies Inc
38% Upside
ARJO B
Arjo AB (publ)
17% Upside
V
100120
Vieworks Co Ltd
42% Upside
FPH
Fisher & Paykel Healthcare Corporation Ltd
12% Downside
IPD
ImpediMed Ltd
123% Upside

Revenue
Forecast

Revenue Estimate
Treace Medical Concepts Inc

For the last 3 years the compound annual growth rate for Treace Medical Concepts Inc's revenue is 48%. The projected CAGR for the next 3 years is 19%.

48%
Past Growth
19%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Treace Medical Concepts Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Treace Medical Concepts Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

See Also

Summary
TMCI intrinsic value, competitors valuation, and company profile.
DCF Valuation
TMCI stock valuation using Discount Cash Flow valuation method.
Relative Valuation
TMCI stock valuation using valuation multiples.
Wall Street Estimates
TMCI price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
TMCI stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TMCI's stock price target?
Price Target
16.17 USD

According to Wall Street analysts, the average 1-year price target for TMCI is 16.17 USD with a low forecast of 14.14 USD and a high forecast of 18.9 USD.

What is Treace Medical Concepts Inc's Revenue forecast?
Projected CAGR
19%

For the last 3 years the compound annual growth rate for Treace Medical Concepts Inc's revenue is 48%. The projected CAGR for the next 3 years is 19%.

ALPHA SPREAD
Join more than 134,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.